STRIDES PHARMA SCIENCE LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 943.8 INR | -0.53% |
|
-0.31% | +45.37% |
| 05-23 | Strides Pharma Science Turns to Consolidated Net Profit in Fiscal Q4; Shares Down 3% | MT |
| 05-22 | Transcript : Strides Pharma Science Limited, Q4 2024 Earnings Call, May 22, 2024 |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Generic Pharmaceuticals
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 1.05B | - | - | - | |||
| 43.77B | ||||||
| 22.83B | ||||||
| 15.56B | ||||||
| 14.34B | ||||||
| 12.96B |
